CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-07 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −2,726 | 2,726 | ||
| 2025-04-07 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +2,694 | 27,801 | ||
| 2025-04-07 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,303 | $20.28 | $26K | 26,498 |
| 2025-04-07 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −2,694 | 2,694 | ||
| 2025-04-07 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +9,992 | 101,506 | ||
| 2025-04-07 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −4,832 | $20.28 | $98K | 96,674 |
| 2025-04-07 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −9,992 | 9,991 | ||
| 2025-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +2,498 | 58,137 | ||
| 2025-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −734 | $20.28 | $15K | 57,403 |
| 2025-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −2,498 | 2,497 | ||
| 2025-04-07 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +2,477 | 28,401 | ||
| 2025-04-07 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −727 | $20.28 | $15K | 27,674 |
| 2025-04-07 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Share Unit | −2,477 | 2,477 | ||
| 2025-04-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +3,933 | 34,212 | ||
| 2025-04-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,666 | $20.28 | $34K | 32,546 |
| 2025-04-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −3,933 | 3,932 | ||
| 2025-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +1,611 | 25,167 | ||
| 2025-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +1,741 | 26,908 | ||
| 2025-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −473 | $21.77 | $10K | 26,435 |
| 2025-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −511 | $21.77 | $11K | 25,924 |
Page 38 of 74 · 1,467 trades